Almac Sustainability Profile
Almac Group, often referred to simply as Almac, is a leading global contract development and manufacturing organisation headquartered in the United States. Established in 2004, Almac has expanded its operational footprint across key regions, including Europe and Asia, solidifying its presence in the pharmaceutical and biotechnology sectors. Specialising in drug development, clinical trial services, and commercial manufacturing, Almac distinguishes itself through its innovative solutions and commitment to quality. The company has achieved significant milestones, including the successful launch of numerous life-saving therapies, positioning itself as a trusted partner for clients in the healthcare industry. With a strong emphasis on customer collaboration and cutting-edge technology, Almac continues to enhance its market position, making a notable impact on the global landscape of drug development and manufacturing.
DitchCarbon Score
How does Almac's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Almac's score of 58 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Almac's reported carbon emissions
In 2023, Almac Group Limited reported total carbon emissions of approximately 164,057,000 kg CO2e. This includes Scope 1 emissions of about 12,728,000 kg CO2e, Scope 2 emissions of approximately 17,434,000 kg CO2e, and significant Scope 3 emissions totalling around 133,895,000 kg CO2e. The latter includes categories such as purchased goods and services (about 66,308,000 kg CO2e) and downstream leased assets (approximately 15,450,000 kg CO2e). Almac has set ambitious climate commitments, aiming for a 50% reduction in absolute Scope 1 and 2 emissions by 2030, using 2019 as the baseline year. Additionally, they have committed to achieving net-zero emissions across all scopes by 2045. Long-term targets include a 95% reduction in Scope 1 and 2 emissions and a 90% reduction in Scope 3 emissions by 2045. These targets are aligned with the Science Based Targets initiative (SBTi), which confirms that Almac's near-term and long-term goals are consistent with the reductions required to limit global warming to 1.5°C. The data reported is not cascaded from any parent organisation, ensuring that these figures and commitments are specific to Almac Group Limited.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 13,675,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 19,146,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 149,516,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is Almac's Industry?
How Carbon Intensive is Almac's Location?
Almac's Scope 3 Categories Breakdown
Almac's Scope 3 emissions, which increased by 3% last year and decreased by approximately 10% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 50% of Scope 3 emissions.
Top Scope 3 Categories
Almac's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Almac has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Shanghai SynTheAll Pharmaceutical Co., Ltd.
Akums Drugs and Pharmaceuticals Limited
Frequently Asked Questions
Common questions about Almac's sustainability data and climate commitments